[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1245]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
AIDS Research Advisory Committee, NIAID.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS
Vaccine Research Subcommittee.
Date: February 8-9, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: Providing information on follow-up studies to define the
correlates of protection observed in the RV144 vaccine efficacy
trial, and to discuss the use of recombinant adenovirus vectors in
AIDS vaccine development.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Salon A-C, Bethesda, MD 20852.
Contact Person: James A. Bradac, PhD, Program Official,
Preclinical Research and Development Branch, Division of AIDS, Room
5116, National Institutes of Health/NIAID, 6700B Rockledge Drive,
Bethesda, MD 20892-7628, 301-435-3754, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1245 Filed 1-20-11; 8:45 am]
BILLING CODE 4140-01-P